Results 191 to 200 of about 349,749 (268)

RECOMBINANT HEPATITIS B VACCINE IN INFANTS

, 1997
Johanna Goldfarb
openalex   +1 more source

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR IMPROVES IMMUNOGENECITY OF HEPATITIS B VACCINE IN HEMODIALYSIS PATIENTS [PDF]

, 2000
PP VARMA, AK SETH, Rohan Malik, Chinmaya Mahapatra, PVS Rana   +4 more
openalex   +1 more source

Management of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: consensus statement

Medical Journal of Australia, EarlyView.
Abstract Introduction Buruli ulcer, caused by Mycobacterium ulcerans, is increasing in incidence and spreading to new areas in southeast Australia. With increasing experience and emerging evidence, this consensus statement considers contemporary data to provide up‐to‐date recommendations to clinicians who may encounter this disease.
Stephen Muhi, Victoria RV Cox, Matthew O'Brien, Jonathan T Priestley, Jodie Hill, Adrian Murrie, Anthony McDonald, Peter Callan, Grant A Jenkin, N Deborah Friedman, Kasha P Singh, Callum Maggs, Peter Kelley, Eugene Athan, Paul DR Johnson, Daniel P O'Brien   +15 more
wiley   +1 more source

Mapping disasters; the application of a disaster-sociological 'Theoretical superstructure' and methodology in a Prima Facie case for investigating the role of hepatitis B vaccines in the contamination of the Canadian blood supply with human immunodef [PDF]

, 2000
Olaf Krassnitzky
openalex   +1 more source

Characteristic, Regulation and Targeting Strategies of Cancer Stem Cells and Their Niche in Digestive System Tumors

MedComm – Oncology, Volume 4, Issue 2, June 2025.
Cancer stem cells, characterized by self‐renewal, differentiation, heterogeneity, plasticity and tumorigenicity, are regulated by intrinsic factors such as signaling pathways, transcription factors, metabolism and noncoding RNAs, as well as environmental cells (including tumor cells, immune cells and stromal cells), environmental factors and distant ...
Zhenzhen Chen, Huanle Qi, Yapeng Xue, Yaqi Zhang, Zhuo Zhang, Shun Xu, Shixin Liao, Xiaoyu Zeng, Jiayi Wu, Xinrui Lv, Qiankun He, Pingping Zhu   +11 more
wiley   +1 more source

Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease [PDF]

, 2001
Mehmet Arslan, Russell H. Wiesner, Corey Sievers, Kathleen S. Egan, Nizar N. Zein   +4 more
openalex   +1 more source

Hepatitis B vaccine: Risks and benefits of universal neonatal vaccination [PDF]

, 2001
C. Raina MacIntyre
openalex   +1 more source

Development of Methods to Produce SARS CoV‐2 Virus‐Like Particles at Scale

Biotechnology and Bioengineering, Volume 122, Issue 5, Page 1118-1129, May 2025.
ABSTRACT The devastating global toll precipitated by the SARS CoV‐2 outbreak and the profound impact of vaccines in stemming that outbreak has established the need for molecular platforms capable of rapidly delivering effective, safe and accessible medical interventions in pandemic preparedness.
Melissa A. Edeling, Linda Earnest, Julio Carrera Montoya, Ashley Huey Yiing Yap, Jamie Mumford, Jason Roberts, Chinn Yi Wong, Dhiraj Hans, Joseph Grima, Nicole Bisset, Jesse Bodle, Steven Rockman, Joseph Torresi   +12 more
wiley   +1 more source

Hepatitis B virus infection after immunization: How serious it is? An updated review. [PDF]

Clin Exp Med
Marjani A, Alavian SM, Nassiri Toosi M, Alavian SH, Abazari MF, Khamseh A, Jazayeri SM.   +6 more
europepmc   +1 more source

The hepatitis B vaccine: Sorting through the B.S. about M.S [PDF]

, 2001
Stephen D. Zucker
openalex   +1 more source